These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 36891783)

  • 21. Male or female sex: considerations and translational aspects in diabetic foot ulcer research using rodent models.
    Rai V; Agrawal DK
    Mol Cell Biochem; 2023 Aug; 478(8):1835-1845. PubMed ID: 36574098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Negative pressure wound therapy, artificial skin and autogenous skin implantation in diabetic foot ulcers.
    Chia-Jui H; Yu L; Jiang YQ; Tan W; Gao GM; Li HB; Han L
    J Wound Care; 2022 Jan; 31(1):40-46. PubMed ID: 35077212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic Foot Ulcers and Cardiac Autonomic Neuropathy.
    Basra R; Papanas N; Farrow F; Karalliedde J; Vas P
    Clin Ther; 2022 Feb; 44(2):323-330. PubMed ID: 34974945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysfunctional Wound Healing in Diabetic Foot Ulcers: New Crossroads.
    Davis FM; Kimball A; Boniakowski A; Gallagher K
    Curr Diab Rep; 2018 Jan; 18(1):2. PubMed ID: 29362914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic foot ulcer, the effect of resource-poor environments on healing time and direct cost: A cohort study during Syrian crisis.
    Alsabek MB; Abdul Aziz AR
    Int Wound J; 2022 Mar; 19(3):531-537. PubMed ID: 34219380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins may be useful in diabetic foot ulceration treatment and prevention.
    Gulcan E; Gulcan A; Erbilen E; Toker S
    Med Hypotheses; 2007; 69(6):1313-5. PubMed ID: 17499447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leveraging Potential of Nanotherapeutics in Management of Diabetic Foot Ulcer.
    Pandey S; Shaif M; Ansari TM; Shamim A; Kushwaha P
    Exp Clin Endocrinol Diabetes; 2022 Oct; 130(10):678-686. PubMed ID: 35240693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a Tissue Oxygenation Flow-Based Index Toward Discerning the Healing Status in Diabetic Foot Ulcers.
    Leiva K; Trinidad A; Gonzalez I; Espinosa A; Zwick T; Levine JE; Rodriguez MA; Lev-Tov H; Wu W; Kirsner RS; Godavarty A
    Adv Wound Care (New Rochelle); 2024 Jan; 13(1):22-33. PubMed ID: 37060195
    [No Abstract]   [Full Text] [Related]  

  • 29. Association of diabetic foot ulcers with chronic vascular diabetic complications in patients with type 2 diabetes.
    Megallaa MH; Ismail AA; Zeitoun MH; Khalifa MS
    Diabetes Metab Syndr; 2019; 13(2):1287-1292. PubMed ID: 31336479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of characteristics and healing course of diabetic foot ulcers by etiological classification: neuropathic, ischemic, and neuro-ischemic type.
    Yotsu RR; Pham NM; Oe M; Nagase T; Sanada H; Hara H; Fukuda S; Fujitani J; Yamamoto-Honda R; Kajio H; Noda M; Tamaki T
    J Diabetes Complications; 2014; 28(4):528-35. PubMed ID: 24846054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased number of Langerhans cells in the epidermis of diabetic foot ulcers correlates with healing outcome.
    Stojadinovic O; Yin N; Lehmann J; Pastar I; Kirsner RS; Tomic-Canic M
    Immunol Res; 2013 Dec; 57(1-3):222-8. PubMed ID: 24277309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keeping an eye on the diabetic foot: The connection between diabetic eye disease and wound healing in the lower extremity.
    Ramsey DJ; Kwan JT; Sharma A
    World J Diabetes; 2022 Dec; 13(12):1035-1048. PubMed ID: 36578874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants and estimation of healing times in diabetic foot ulcers.
    Zimny S; Schatz H; Pfohl M
    J Diabetes Complications; 2002; 16(5):327-32. PubMed ID: 12200075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical Erythropoietin Accelerates Wound Closure in Patients with Diabetic Foot Ulcers: A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial.
    Hamed S; Ullmann Y; Belokopytov M; Shoufani A; Kabha H; Masri S; Feldbrin Z; Kogan L; Kruchevsky D; Najjar R; Liu PY; Kerihuel JC; Akita S; Teot L
    Rejuvenation Res; 2021 Aug; 24(4):251-261. PubMed ID: 33504262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular reprogramming of diabetic foot ulcer fibroblasts triggers pro-healing miRNA-mediated epigenetic signature.
    Pastar I; Marjanovic J; Liang L; Stone RC; Kashpur O; Jozic I; Head CR; Smith A; Gerami-Naini B; Garlick JA; Tomic-Canic M
    Exp Dermatol; 2021 Aug; 30(8):1065-1072. PubMed ID: 34114688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-coding RNAs in diabetic foot ulcer- a focus on infected wounds.
    Qin B; Peng Q; Dong H; Lei L; Wu S
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3740. PubMed ID: 37839046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intralesional epidermal growth factor therapy in recalcitrant diabetic foot ulcers.
    Özker E
    J Wound Care; 2023 Apr; 32(Sup4):S14-S21. PubMed ID: 37029977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic keratinocyte for intractable chronic diabetic foot ulcers: A prospective observational study.
    Hwang YG; Lee JW; Park KH; Han SH
    Int Wound J; 2019 Apr; 16(2):486-491. PubMed ID: 30604568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategy for Treatment of Infected Diabetic Foot Ulcers.
    Chang M; Nguyen TT
    Acc Chem Res; 2021 Mar; 54(5):1080-1093. PubMed ID: 33596041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Lower IL-34 Expression Is Associated with Non-Healing Diabetic Foot Ulcers.
    Zheng A; Xu Y; Cen N; Wu B
    Comb Chem High Throughput Screen; 2024; 27(10):1533-1543. PubMed ID: 37888825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.